NCT04246528 SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF) Status COMPLETED Phase NA
NCT04244916 MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis Status TERMINATED Phase N/A
NCT04212247 Trial on Outpatients With Systemic Sclerosis Treated With Well-Being Therapy or With a Control Therapy Status COMPLETED Phase NA
NCT04206644 Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04132206 Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients Status RECRUITING Phase N/A
NCT04001556 RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc) Status COMPLETED Phase NA
NCT03976648 A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis Status TERMINATED Phase PHASE2
NCT03941184 Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity Status COMPLETED Phase N/A
NCT03937271 Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome Status WITHDRAWN Phase N/A
NCT03889509 A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis Status COMPLETED Phase N/A
NCT03844061 Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis Status RECRUITING Phase PHASE2
NCT03819777 Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) Status UNKNOWN Phase N/A
NCT03817424 A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Status COMPLETED Phase PHASE1
NCT03798366 A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis Status COMPLETED Phase PHASE2